[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENT

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Veterinary Dermatology Drugs Market

3.3       Key Market Trends

3.3.1   Drivers

3.3.2   Restraints

3.3.3   Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1   Bargaining Power of Suppliers

3.4.2   Bargaining Power of Buyers

3.4.3   Threat of Substitution

3.4.4   Threat of New Entrants

3.4.5   Competitive Rivalry

4.         By Drug

4.1       Introduction

4.1.1   Market Size & Forecast (Value)

4.2       Non-steroidal anti-inflammatory drugs (NSAIDS)

4.3       Antibiotics

4.4       Veterinary antifungal drug

5.          By Animal Type

5.1       Introduction

5.1.1   Market Size & Forecast (Value)

5.2       Large animals

5.3       Small animals

6.         By End Users

6.1       Introduction

6.1.1   Market Size & Forecast (Value)

6.2       Veterinary Hospitals

6.3       Veterinary Clinics

7.         By Regional Overview        

7.1      Introduction 

7.1.1   Market Size & Forecast (Value)      

7.2      America         

7.2.1   North America          

7.2.1.1 U.S.   

7.2.1.1.1          By Drug         

7.2.1.1.2          By Animal Type       

7.2.1.2 Canada         

7.2.1.2.1          By Drug         

7.2.1.2.2          By Animal Type       

7.2.1.3 Mexico          

7.2.1.3.1          By Drug         

7.2.1.3.2          By Animal Type       

7.2.2   South America          

7.2.2.1            By Drug

7.2.2.2            By Animal Type

7.3      Europe           

7.3.1   Market Size & Forecast (Value)      

7.3.2   Western Europe

7.3.2.1 Germany      

7.3.2.1.1         By Drug          

8.3.2.1.2         By Animal Type        

7.3.2.2 France           

7.3.2.2.1         By Drug          

7.3.2.2.2         By Animal Type        

7.3.2.3 U.K    

7.3.2.3.1         By Drug          

7.3.2.3.2         By Animal Type        

7.3.2.4 Italy   

7.3.2.4.1         By Drug          

7.3.2.4.2         By Animal Type        

7.3.2.5 Spain 

7.3.2.5.1         By Drug          

7.3.2.5.2         By Animal Type        

7.3.2.6 Rest of Western Europe     

7.3.2.6.1         By Drug

7.3.2.6.2         By Animal Type

7.3.3   Eastern Europe

7.4      Asia Pacific    

7.4.1   Market Size & Forecast (Value)      

7.4.2   China 

7.4.2.1             By Drug

7.4.2.2             By Animal Type

7.4.3   India

7.4.3.1             By Drug

7.4.3.2             By Animal Type

7.4.4   Japan 

7.4.4.1             By Drug          

7.4.4.2             By Animal Type        

7.4.5   South Korea  

7.4.5.1             By Drug          

7.4.5.2             By Animal Type        

7.4.6   Australia        

7.4.6.1            By Drug          

7.4.6.2            By Animal Type        

7.4.7   Rest of Asia-Pacific   

7.4.7.1            By Drug          

7.4.7.2            By Animal Type        

7.5       Middle East & Africa

7.5.1   Market Size & Forecast (Value)      

7.5.2   The Middle East

7.5.2.1     South Africa

7.5.2.1.1         By Drug          

7.5.2.1.2         By Animal Type        

7.5.2.2     UAE

7.5.2.2.1         By Drug         

7.5.2.2.2         By Animal Type       

7.5.2.3     Qatar

7.5.2.3.1         By Drug         

7.5.2.3.2         By Animal Type       

7.5.2.4     Rest of Middle East

7.5.2.4.1         By Drug

7.5.2.4 2         By Animal Type

7.5.3   Africa

7.5.3.1             By Drug          

7.5.3.2             By Animal Type

8.         Company Profile                 

8.1       Bayer HealthCare Animal Health Inc.

8.1.1   Company Overview 

8.1.2   Financial Performance         

8.1.3   Recent Developments         

8.1.4   Product Portfolio     

8.2       Boehringer Ingelheim Vetmedica, Inc.

8.2.1   Company Overview 

8.2.2   Financial Performance         

8.2.3   Recent Developments         

8.2.4   Product Portfolio     

8.3       Zoetis Inc.

8.3.1   Company Overview 

8.3.2   Financial Performance         

8.3.3   Recent Developments         

8.3.4   Product Portfolio     

8.4       Elanco

8.4.1   Company Overview 

8.4.2   Financial Performance         

8.4.3   Recent Developments         

8.4.4   Product Portfolio     

8.5       IDEXX Laboratories

8.5.1   Company Overview 

8.5.2   Financial Performance         

8.5.3   Recent Developments         

8.5.4   Product Portfolio     

8.6       Boehringer Ingelheim International GmbH.

8.6.1   Company Overview 

8.6.2   Financial Performance         

8.6.3   Recent Developments         

8.6.4   Product Portfolio     

8.7       Vetoquinol S.A.

8.7.1   Company Overview 

8.7.2   Financial Performance         

8.7.3   Recent Developments         

8.7.4   Product Portfolio     

8.8       Virbac

8.8.1   Company Overview 

8.8.2   Financial Performance         

8.8.3   Recent Developments         

8.8.4   Product Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports